Cat-cloning company to close its doors
Genetic Savings & Clone, a biotechnology company that sold cloned pets, sent letters to its customers last month informing them it will close at the end of the year because of little demand for cloned cats. The company had recently reduced the price from $50,000 to $32,000.
The letters said the Sausalito company was not accepting new orders for clones because it was "unable to develop the technology to the point that cloning pets is commercially viable."
Company chief executive Lou Hawthorne did not immediately return telephone calls Wednesday. A message on the company's answering machine said it was no longer taking orders and referred customers interested in freezing their pets genetic material to the Austin, Texas-based biotechnology company ViaGen Inc.
A ViaGen spokeswoman confirmed that Genetic Savings & Clone had closed and had refunded cloning fees.
The company was launched by billionaire and University of Phoenix founder John Sperling, who had hoped to have his hunting dog, Missy, cloned — a feat that was never accomplished.
Since the company opened for business in 2000, it was behind the creation of five cloned cats, but sold only two to paying customers. The first commercially cloned cat was named Little Nicky and was delivered to a Texas woman saddened by the loss of a cat she owned for 17 years.
The kitten cost its owner $50,000 and was created from DNA from her beloved cat, Nicky, who died the previous year. That kitten's creation and sale reignited fierce ethical and scientific debate over cloning technology, which is rapidly advancing.
Aside from human cloning, which has not been achieved even at the microscopic embryo stage, no cloning project has fueled more debate than the marketing plans of Genetic Savings & Clone.
Animals rights activists complained that new feline production systems aren't needed because thousands of stray cats are euthanized each year for want of homes. Those groups were elated Wednesday at news of the company's demise.
"It's no surprise the demand for cloned pets is basically nonexistent, and we're very pleased that Genetics Savings & Clone's attempt to run a cloning pet store was a spectacular flop," said Wayne Pacelle, head of the Humane Society of the United States. "It's not just a bad business venture, but also an operation grounded on the misuse of animals."
Pacelle and other groups argue that cloning is still primitive and fails more often than it succeeds.
"For every successful clone, dozens fail and die prematurely, have physical abnormalities, and face chronic pain and suffering," Pacelle said. "Cloning is at odds with basic animal welfare considerations."
Read Full Story
The letters said the Sausalito company was not accepting new orders for clones because it was "unable to develop the technology to the point that cloning pets is commercially viable."
Company chief executive Lou Hawthorne did not immediately return telephone calls Wednesday. A message on the company's answering machine said it was no longer taking orders and referred customers interested in freezing their pets genetic material to the Austin, Texas-based biotechnology company ViaGen Inc.
A ViaGen spokeswoman confirmed that Genetic Savings & Clone had closed and had refunded cloning fees.
The company was launched by billionaire and University of Phoenix founder John Sperling, who had hoped to have his hunting dog, Missy, cloned — a feat that was never accomplished.
Since the company opened for business in 2000, it was behind the creation of five cloned cats, but sold only two to paying customers. The first commercially cloned cat was named Little Nicky and was delivered to a Texas woman saddened by the loss of a cat she owned for 17 years.
The kitten cost its owner $50,000 and was created from DNA from her beloved cat, Nicky, who died the previous year. That kitten's creation and sale reignited fierce ethical and scientific debate over cloning technology, which is rapidly advancing.
Aside from human cloning, which has not been achieved even at the microscopic embryo stage, no cloning project has fueled more debate than the marketing plans of Genetic Savings & Clone.
Animals rights activists complained that new feline production systems aren't needed because thousands of stray cats are euthanized each year for want of homes. Those groups were elated Wednesday at news of the company's demise.
"It's no surprise the demand for cloned pets is basically nonexistent, and we're very pleased that Genetics Savings & Clone's attempt to run a cloning pet store was a spectacular flop," said Wayne Pacelle, head of the Humane Society of the United States. "It's not just a bad business venture, but also an operation grounded on the misuse of animals."
Pacelle and other groups argue that cloning is still primitive and fails more often than it succeeds.
"For every successful clone, dozens fail and die prematurely, have physical abnormalities, and face chronic pain and suffering," Pacelle said. "Cloning is at odds with basic animal welfare considerations."
Read Full Story
Health Headlines MORE »
For every 10 g per day increase in soluble fiber intake, a woman may reduce her risk of breast cancer by up to 26%.
Peptides from soybeans modulate neurotransmitters, thereby helping to boost circulation in the brain.
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
ANTI-AGING TIP OF THE DAY
In Working Order
Men and women who stay mentally engaged in their original occupational field fare after retirement fare best mentally. University of Maryland (Maryland, USA) researchers studied 12,189 retired men and women, ages 51 to 61 years at the beginning of the study. The team revealed that those retirees who continued to work in a bridge job experienced fewer major diseases...
»
MORE
